Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Cosmetic surgery

 

Indian inbound medical travel ‘a trickle’ as operators consider costs

Medical travel to India is still 'a trickle' compared to pre-COVID figures although restrictions have also increased the supply of specialists locally, said panellists at HBI's State of the Region's South Asia session. Like elsewhere, the pandemic has forced a re-think of how operators manage costs. 

European operators brace for second wave

COVID's second wave looks either imminent, or is already starting to hit in many jurisdictions. Wave one saw lockdowns and closures - and not all closures were temporary. Will wave two be any different? HBI has been talking to operators across EMEA to see if forewarned is forearmed, how they predict the next few months will go, and what lessons have been learned.

What does a good post-COVID outpatient clinic look like?

Outpatient activity all but came to a standstill as the COVID crisis tightened its grip. A panel of experts comprising Richard Banks, Chief Strategy Officer at international fertility player Virtus Health, Martin Bundschu, Director at Germany-based optical specialist Smile Eyes, former Colosseum Dental CEO Tomas Aubell, and L.E.K. Consulting's global co-head of healthcare Ben Faircloth joined an HBI-365 audience last week to discuss what a good outpatient clinic post-COVID might look like, and how markets have been affected.

Adding value post-COVID – where are the easy wins?

How do you add value to a business in a post COVID world - and are there any easy wins for new acquisitions? On Wednesday last week, an online audience heard HBI365's lively Q&A panel with with Ameos CEO Dr Axel Paeger, McKinsey partner Sebastian Sieler, and L Catterton managing partner Chinta Bhagat.

COVID impact less severe than expected for cosmetic group

HBI talks to Tony Veverka, CEO of Transform Hospital Group, about the groups experience of reopening its core cosmetic business after supporting the NHS though COVID since the start of April, the affect on its revenue, and his hope a new understanding might be reached with the NHS.

COVID-19 and Emerging Market healthcare

We talk to two of the world's largest investors in emerging market health care about Covid's likely impact. Despite so far much lower death rates, the initial effect on health care operators has been worse than in Europe. Covid is set to destroy several motors for growth such as healthcare tourism and the deployment of […]

Interview: Tony Veverka, CEO, Transform

HBI talks to Tony Veverka, CEO of cosmetic surgery specialist Transform Hospital Group, about his business, and the market pre-and (speculatively) post-COVID.

Find Us